The researchers compared this group with two other groups: recipients who were still taking their immunosuppressive medication and had healthy kidneys, and healthy, non-transplant controls.
研究人员将这一组与其他两组(仍然使用免疫抑制药物并具有健康肾脏的受者,以及健康非移植对照组)进行了比较。
The researchers compared this group with two other groups: recipients who were still taking their immunosuppressive medication and had healthy kidneys, and healthy, non-transplant controls.
研究人员将这一组与其他两组(仍然使用免疫抑制药物并具有健康肾脏的受者,以及健康非移植对照组)进行了比较。
应用推荐